Calcio levofolinato Teva Generics 175 mg polvere per soluzione per infusione
Sponsors
Gilead Sciences Inc., IRCCS Istituto Nazionale Tumori Fondazione Pascale
Conditions
Metastatic Colorectal Cancer (mCRC)Patients with metastatic colorectal cancer (mCRC) RAS-mutant
Phase 2
A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
CompletedCTIS2022-500177-13-00
Start: 2023-06-02End: 2024-06-26Target: 46Updated: 2024-04-02
Regorafenib as second-line treatment of patients with RAS-mutant advanced colorectal cancer: a multicentre, phase 2 study - STREAM-2
Not yet recruitingCTIS2024-519669-23-00
Target: 60Updated: 2025-10-02